Strategic Blueprint, LLC Edwards Lifesciences Corp Transaction History

Strategic Blueprint, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$86.5 - $128.27 $256,905 - $380,961	-2,970 Closed	0 $0
Q1 2022 Aug 12, 2022	BUY	$101.96 - $128.34 $45,066 - $56,726	442 Added 17.48%	2,970 $350,000
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $63,928 - $78,538	601 Added 31.19%	2,528 $327,000
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $151,174 - $180,319	-1,469 Reduced 43.26%	1,927 $218,000
Q2 2021 Aug 12, 2021	SELL	$83.84 - $104.76 $39,237 - $49,027	-468 Reduced 12.11%	3,396 $351,000
Q1 2021 May 10, 2021	BUY	$78.68 - $90.67 $10,228 - $11,787	130 Added 3.48%	3,864 $323,000
Q4 2020 Jan 26, 2021	SELL	$71.69 - $91.23 $141,587 - $180,179	-1,975 Reduced 34.59%	3,734 $341,000
Q3 2020 Oct 27, 2020	BUY	$67.19 - $87.44 $383,587 - $499,194	5,709 New	5,709 $456,000
Q4 2019 Jan 10, 2020	SELL	$71.7 - $82.09 $61,303 - $70,186	-855 Closed	0 $0
Q3 2019 Oct 16, 2019	BUY	$61.55 - $75.43 $52,625 - $64,492	855 New	855 $188,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Strategic Blueprint, LLC, based on Form 13F filings with the SEC.

Stay updated on Strategic Blueprint, LLC with notifications on news.